Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis

Gene Therapy volume 10, pages 1559–1566 (2003)Cite this article

Abstract

Although a variety of gene transfer methods to the liver have been designed, there are some problems such as the transfection efficiency and safety. In the present study, we developed a modified method of gene transfer into the liver by infusion of plasmid DNA via the portal vein followed by electroporation. After green fluorescence protein gene transfer, transgene expressions were detected in 24 h, and then maximally at 3 days, and persisted for 3 weeks. Histological analysis revealed that very mild tissue damage was induced in the liver to which electroporation was applied. In the second study, human hepatocyte growth factor (HGF) was more detected in the liver injected with 500 μg of human HGF gene than 100 μg of human HGF gene. However, serum HGF did not increase with 100 or 500 μg of human HGF gene. Moreover, 500 μg of HGF gene transfer into the liver by using this method could achieve the long survival of all dimethylnitrosamine-treated rats and attenuate the fibrous regions in the liver. These results suggest that HGF gene transfer into the liver via the portal vein using electroporation might be one of the useful methods for the treatment of various liver diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Li Q et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403–409.

    Article  CAS  Google Scholar 

  2. Mulligan RC . The basic science of gene therapy. Science 1993; 243: 375–378.

    Google Scholar 

  3. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362–369.

    Article  CAS  Google Scholar 

  4. Marshall E . Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244–2245.

    Article  CAS  Google Scholar 

  5. Hickman MA et al. Gene expression following direct injection of DNA into the liver. Hum Gene Ther 1994; 5: 1477–1483.

    Article  CAS  Google Scholar 

  6. Kaneda Y et al. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989; 243: 375–378.

    Article  CAS  Google Scholar 

  7. Kaneda Y et al. Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem 1989; 264: 12126–12129.

    CAS  Google Scholar 

  8. Kato K et al. Expression of hepatitis B virus surface antigen in adult rat liver. J Biol Chem 1991; 266: 3361–3364.

    CAS  Google Scholar 

  9. Heller R et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389: 225–228.

    Article  CAS  Google Scholar 

  10. Suzuki T et al. Direct gene transfer rat liver cells by in vivo electroporation. FEBS Lett 1998; 425: 436–440.

    Article  CAS  Google Scholar 

  11. Muramatsu T et al. In vivo gene electroporation nutritionally-regulated foreign gene expression in the liver. Int J Mol Med 2001; 7: 61–66.

    CAS  PubMed  Google Scholar 

  12. Nakamura T et al. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986; 83: 6489–6493.

    Article  CAS  Google Scholar 

  13. Nakamura T et al. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987; 224: 311–316.

    Article  CAS  Google Scholar 

  14. Nakamura T et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440–443.

    Article  CAS  Google Scholar 

  15. Matsumoto K, Nakamura T . Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 1992; 3: 27–54.

    CAS  PubMed  Google Scholar 

  16. Boros P, Miller CM . Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293–295.

    Article  CAS  Google Scholar 

  17. Ricci G et al. Hepatocyte growth factor (HGF) receptor expression and role of HGF during embryonic mouse testis development. Dev Biol 1999; 216: 340–347.

    Article  CAS  Google Scholar 

  18. Kasai K et al. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30: 151–159.

    Article  Google Scholar 

  19. Liu Y . Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 1999; 277: F624–G633.

    CAS  PubMed  Google Scholar 

  20. Natsume M et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol 1999; 66: 601–608.

    Article  CAS  Google Scholar 

  21. Yasuda H et al. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 25: 634–642.

    Google Scholar 

  22. Michalopoulos GK, DeFrances MC . Liver regeneration. Science 1997; 276: 60–66.

    Article  CAS  Google Scholar 

  23. Tahara M, Matsumoto K, Nukiwa T, Nakamura T . Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Invest 1999; 103: 313–320.

    Article  CAS  Google Scholar 

  24. Okano J et al. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 1997; 26: 1241–1249.

    CAS  PubMed  Google Scholar 

  25. Xue F et al. Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut 2002; 50: 558–562.

    Article  CAS  Google Scholar 

  26. Ueki T et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226–230.

    Article  CAS  Google Scholar 

  27. Fujimoto J . Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis. Gene Therapy 1999; 6: 305–306.

    Article  CAS  Google Scholar 

  28. Ferry N et al. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 1991; 88: 8377–8381.

    Article  CAS  Google Scholar 

  29. Rabinowitz JE, Xiao W, Samulski RJ . Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology 1999; 265: 274–285.

    Article  CAS  Google Scholar 

  30. Powell S et al. In vitro analysis of transformation potential associated with retroviral vector insertions. Hum Gene Ther 1999; 10: 2123–2132.

    Article  CAS  Google Scholar 

  31. Umeda Y et al. Nonviral gene gun-mediated CTLA4-Ig gene transfer for modification of donor organs. Transplant Proc 2001; 33: 243–245.

    Article  CAS  Google Scholar 

  32. Matsuno Y et al. Suppression of graft coronary arteriosclerosis by gene gun-mediated CTLA4-Ig gene transfer. Transplant Proc 2002; 34: 2622–2623.

    Article  Google Scholar 

  33. Umeda Y et al. Gene gun-mediated CTLA4-Ig gene transfer for modification of donor organs. Transplant Proc 2002; 34: 2619–2621.

    Article  Google Scholar 

  34. Liu F et al. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Therapy 2002; 9: 1116–1119.

    Article  CAS  Google Scholar 

  35. Budker V et al. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther 1996; 3: 593–598.

    CAS  Google Scholar 

  36. Zhang G et al. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Therapy 1997; 8: 1763–1772.

    Article  CAS  Google Scholar 

  37. Matsuda Y et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997; 26: 81–89.

    Article  CAS  Google Scholar 

  38. Kawaida K et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357–4361.

    Article  CAS  Google Scholar 

  39. Liu KX et al. Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol 1992; 263: G642–G649.

    Article  CAS  Google Scholar 

  40. Appasamy R et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993; 68: 270–276.

    CAS  PubMed  Google Scholar 

  41. Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193–199.

    Article  CAS  Google Scholar 

  42. Zhang G, Gurtu V, Kain SR . An enhanced green fluorecent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 1996; 227: 707–711.

    Article  CAS  Google Scholar 

  43. Okabe M et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett 1997; 407: 313–319.

    Article  CAS  Google Scholar 

  44. Seki T et al. Organization of human hepatocyte growth factor-encoding gene. Gene 1991; 102: 213–219.

    Article  CAS  Google Scholar 

  45. Yamada A et al. Rapid and sensitve enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 1995; 16: 105–114.

    Article  CAS  Google Scholar 

  46. Jezequel AM et al. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 1989; 8: 42–45.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Surgery, Gifu University School of Medicine, Gifu, Japan

    Y Matsuno, H Iwata, Y Umeda, H Takagi, Y Mori & H Hirose

  2. School of Allied Health Sciences, Faculty of Medicine, Osaka University, Suita, Japan

    A Kosugi

  3. Division of Molecular Regenerative Medicine, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Suita, Japan

    K Matsumoto & T Nakamura

Authors
  1. Y Matsuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Umeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Kosugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsuno, Y., Iwata, H., Umeda, Y. et al. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis. Gene Ther 10, 1559–1566 (2003). https://doi.org/10.1038/sj.gt.3302052

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302052

Keywords

This article is cited by

Search

Advanced search

Quick links